Results 221 to 230 of about 94,803 (309)

Waiting Time Prioritisation for Public and Private Providers: Evidence From Hip Replacement Surgery

open access: yesHealth Economics, Volume 35, Issue 11, Page 1744-1763, November 2026.
ABSTRACT Waiting times for planned health care treatments have been increasing in England and other OECD countries. One policy to reduce the impact of waiting times on patients' health is for doctors to prioritise patients according to their health status. This study tests the extent to which publicly‐funded patients in poorer health are prioritised on
Panos Kasteridis   +2 more
wiley   +1 more source

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

open access: yesHead &Neck, Volume 48, Issue 11, Page 3152-3172, November 2026.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell   +11 more
wiley   +1 more source

Effect of Hypertension on the Health-related Quality of Life of People Living with Hypertension in Dschang, Cameroon: Comparative Analytical Cross-section. [PDF]

open access: yesJ Epidemiol Glob Health
Ngambu OS   +6 more
europepmc   +1 more source

Feasibility of a Multimodal Lifestyle Intervention Programme for Patients With Ulcerative Colitis: A Single‐Arm Pilot Study

open access: yesJCC Plus, Volume 1, Issue 6, November 2026.
ABSTRACT Introduction Although individual lifestyle interventions have shown promise in improving well‐being in patients with ulcerative colitis (UC), the feasibility of a multimodal approach remains unclear. This study assessed the feasibility of a multimodal lifestyle intervention programme.
Dorien Oomkens   +7 more
wiley   +1 more source

Potentially inappropriate care at the end of life in patients with glioblastoma: A single-center observational cohort study. [PDF]

open access: yesNeuro Oncol
Pieterman RM   +6 more
europepmc   +1 more source

Clinical History and Burden of Gaucher Disease Type 3: A Cross‐Sectional Multinational Study

open access: yesJIMD Reports, Volume 67, Issue 6, November 2026.
ABSTRACT Gaucher disease Type 3 (GD3) is a rare genetic neurodegenerative disorder, characterized by heterogeneity in symptom burden, disease severity, and progression. There is limited evidence on the burden of GD3. This retrospective, cross‐sectional study estimated the burden of illness associated with GD3 using descriptive analyses of clinician ...
Eugen Mengel   +10 more
wiley   +1 more source

CRISPR Technology: From Bench to Bedside Applications

open access: yesMedComm, Volume 7, Issue 11, November 2026.
This review systematically dissects the molecular mechanisms, advantages, and limitations of core CRISPR editing platforms including base editors (Panel A) and prime editing (Panel B); summarizes pivotal clinical data across hemoglobinopathies, CAR‐T immunotherapy, muscular dystrophy, cystic fibrosis, cardiometabolic diseases, and rare monogenic ...
Xinzhi Ma, Lingyu Li, Yingli Sun
wiley   +1 more source

Current Evidence of Rehabilitation for Patients with Drug-resistant Epilepsy: Systematic Review and Meta-analysis. [PDF]

open access: yesProg Rehabil Med
Inaba T   +9 more
europepmc   +1 more source

Impact of Dupilumab Therapy on Skin Barrier Function in Patients With Moderate‐to‐Severe Atopic Dermatitis: A Phase IV, Non‐Randomized, Open‐Label, Parallel‐Group Clinical Study

open access: yesMedComm, Volume 7, Issue 11, November 2026.
This 16‑week study assessed impact of dupilumab on skin barrier function in patients with moderate‑to‑severe atopic dermatitis (AD). Tape‑stripped stratum corneum samples for multi‑omic profiling, alongside transepidermal water loss measurements, were collected from lesional/non‑lesional AD skin and healthy controls at seven time points.
Taoming Liu   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy